To analyze the efficacy and complications of microvascular decompression for hemifacial spasm.
Study Design
Retrospective study.
Setting
Regional hospital.
Methods
Fifty-five patients with hemifacial spasm were treated by microvascular decompression. All patients with hemifacial spasm who underwent retrosigmoid microvascular decompression from May 2004 to January 2017 were included. Patients with no conflict on preoperative magnetic resonance imaging or with an alternate diagnosis were excluded.
Results
The overall cure rate was 83.64%, with an average follow-up of 7.4 years. A left-sided hemifacial spasm was a healing-promoting factor (P = .01). The median healing was 0.03 months, and the mean was 6 months. The efficacy remained high in the medium term (88% at 3 years), long term (90.24% at 5 years), and very long term (90.48% at 8 years). The recurrence rate was 9.8%. Favorable criteria included a right-sided spasm (P = .01) and an average age of 62 years (P = .03). The specific complications were permanent facial palsy (3.63%), unilateral deafness (5.45%), and hearing loss (3.63%). No death was reported. Regarding the quality of life of the patients, 94.7% had a modified HFS-8 postoperative score of 0 (Hemifacial Spasm 8 Quality of Life Scale).
Conclusion
Microvascular decompression for hemifacial spasm is an effective and lasting technique. Its low rate of complications and the considerable quality-of-life improvement should lead surgeons to propose it to patients as soon as botulinum toxin injections become ineffective or poorly tolerated.
AugerRGWhisnantJP. Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984. Arch Neurol. 1990;47(11):1233-1234.
2.
WangAJankovicJ. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998;21(12):1740-1747.
3.
HeuserKKertyEEidePKCvancarovaMDietrichsE. Microvascular decompression for hemifacial spasm: postoperative neurologic follow-up and evaluation of life quality. Eur J Neurol. 2007;14(3):335-340.
4.
TanEKFook-ChongSLumS-YThumbooJ. Validation of a short disease specific quality of life scale for hemifacial spasm: correlation with SF-36. J Neurol Neurosurg Psychiatry. 2005;76(12):1707-1710.
5.
TanE-KFook-ChongSLumS-YLimE. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci. 2004;219(1-2):151-155.
6.
BatistiJPMKleinfelderADFGalliNBMoroAMunhozRPTeiveHAG. Treatment of hemifacial spasm with botulinum toxin type A: effective, long lasting and well tolerated. Arq Neuropsiquiatr. 2017;75(2):87-91.
7.
BentivoglioARFasanoAIalongoTSoletiFLo FermoSAlbaneseA. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm. Eur J Neurol. 2009;16(3):392-398.
8.
DefazioGAbbruzzeseGGirlandaP, et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol. 2002;59(3):418-420.
9.
TanNCTanEKKhinLW. Diagnosis and misdiagnosis of hemifacial spasm: a clinical and video study. J Clin Neurosci. 2004;11(2):142-144.
10.
LefaucheurJ-PBen DaamerNSanglaSLe GuerinelC. Diagnosis of primary hemifacial spasm. Neurochirurgie. 2018;64(2):82-86.
11.
MartinezARMNunesMBImmichND, et al. Misdiagnosis of hemifacial spasm is a frequent event in the primary care setting. Arq Neuropsiquiatr. 2014;72(2):119-122.
12.
JogMChouinardSHobsonD, et al. Causes for treatment delays in dystonia and hemifacial spasm: a Canadian survey. Can J Neurol Sci. 2011;38(5):704-711.
13.
FergusonJH. Hemifacial spasm and the facial nucleus. Ann Neurol. 1978;4(2):97-103.
14.
LiuMXiaLZhongJLiBDouNLiS. A comparative study of intraoperative findings and postoperative outcomes between atypical and typical hemifacial spasms. Neurosurg Rev. 2018;41(2):593-597.
15.
SharmaRGargKAgarwalS, et al. Microvascular decompression for hemifacial spasm: a systematic review of vascular pathology, long term treatment efficacy and safety. Neurol India. 2017;65(3):493-505.
16.
ChengJLeiDHuiXZhangH. Improvement of quality of life in patients with hemifacial spasm after microvascular decompression: a prospective study. World Neurosurg. 2017;107(suppl C):549-553.
17.
SindouMMercierP. Microvascular decompression for hemifacial spasm: outcome on spasm and complications: a review. Neurochirurgie. 2018;64(2):106-116.
18.
JoKWKongD-SParkK. Microvascular decompression for hemifacial spasm: long-term outcome and prognostic factors, with emphasis on delayed cure. Neurosurg Rev. 2013;36(2):297-301.
19.
MillerLEMillerVM. Safety and effectiveness of microvascular decompression for treatment of hemifacial spasm: a systematic review. Br J Neurosurg. 2012;26(4):438-444.
20.
MontavaMRossiVCurtoFaisCLManciniJLavieilleJ-P. Long-term surgical results in microvascular decompression for hemifacial spasm: efficacy, morbidity and quality of life. Acta Otorhinolaryngol Ital. 2016;36(3):220-227.
21.
BroggiMAcerbiFFerroliPTringaliGSchiaritiMBroggiG. Microvascular decompression for neurovascular conflicts in the cerebello-pontine angle: which role for endoscopy?Acta Neurochir (Wien). 2013;155(9):1709-1716.
22.
El RefaeeELangnerSBaldaufJMatthesMKirschMSchroederHWS. Value of 3-dimensional high-resolution magnetic resonance imaging in detecting the offending vessel in hemifacial spasm: comparison with intraoperative high definition endoscopic visualization. Neurosurgery. 2013;73(1):58-67.
23.
FerreiraMWalcottBPNahedBVSekharLN. Vertebral artery pexy for microvascular decompression of the facial nerve in the treatment of hemifacial spasm. J Neurosurg. 2011;114(6):1800-1804.
24.
LeeSHParkJSAhnYH. Bioglue-coated Teflon sling technique in microvascular decompression for hemifacial spasm involving the vertebral artery. J Korean Neurosurg Soc. 2016;59(5):505-511.
25.
JiangXWuMFuX, et al. Microvascular decompression for hemifacial spasm associated with vertebral artery: biomedical glue-coated teflon sling transposition technique. World Neurosurg. 2018;120:e342-e348.
26.
SindouMLestonJMDecullierEChapuisF. Microvascular decompression for trigeminal neuralgia: the importance of a noncompressive technique—Kaplan-Meier analysis in a consecutive series of 330 patients. Neurosurgery. 2008;63(4)(suppl 2):341-350.
27.
ZaidiHAAwadA-WChowdhrySAFuscoDNakajiPSpetzlerRF. Microvascular decompression for hemifacial spasm secondary to vertebrobasilar dolichoectasia: surgical strategies, technical nuances and clinical outcomes. J Clin Neurosci. 2015;22(1):62-68.
28.
SindouMKeravelY. Neurosurgical treatment of primary hemifacial spasm with microvascular decompression. Neurochirurgie. 2009;55(2):236-247.
29.
JiangCXuWDaiYLuTJinWLiangW. Failed microvascular decompression surgery for hemifacial spasm: a retrospective clinical study of reoperations. Acta Neurochir (Wien). 2017;159(2):259-263.
30.
MarneffeVPoloGFischerCSindouM. Microsurgical vascular decompression for hemifacial spasm: follow-up over one year, clinical results and prognostic factors. Study of a series of 100 cases. Neurochirurgie. 2003;49(5):527-535.
31.
ChangWSChungJCKimJPChungSSChangJW. Delayed recurrence of hemifacial spasm after successful microvascular decompression: follow-up results at least 5 years after surgery. Acta Neurochir (Wien). 2012;154(9):1613-1619.
32.
PaynerTDTewJM. Recurrence of hemifacial spasm after microvascular decompression. Neurosurgery. 1996;38(4):686-690.
33.
WangXThirumalaPDShahA, et al. Microvascular decompression for hemifacial spasm: focus on late reoperation. Neurosurg Rev. 2013;36(4):637-643.
34.
El DamatyARosenstengelCMatthesMBaldaufJSchroederHWS. The value of lateral spread response monitoring in predicting the clinical outcome after microvascular decompression in hemifacial spasm: a prospective study on 100 patients. Neurosurg Rev. 2016;39(3):455-466.
35.
KiyaNBannurUYamauchiAYoshidaKKatoYKannoT. Monitoring of facial evoked EMG for hemifacial spasm: a critical analysis of its prognostic value. Acta Neurochir (Wien). 2001;143(4):365-368.
36.
LiNZhaoW-GPuC-HYangW-L. Correlation between cerebellar retraction and hearing loss after microvascular decompression for hemifacial spasm: a prospective study. World Neurosurg. 2017;102:97-101.
37.
KimHRRheeD-JKongD-SParkK. Prognostic factors of hemifacial spasm after microvascular decompression. J Korean Neurosurg Soc. 2009;45(6):336-340.
38.
ZhaoHLiGZhangX, et al. Long-term efficacy of initial microvascular decompression versus subsequent microvascular decompression for idiopathic hemifacial spasm. World Neurosurg. 2018;109:e778-e782.
39.
CoteDJDasenbrockHHGormleyWBSmithTRDunnIF. Adverse events after microvascular decompression: a National Surgical Quality Improvement Program analysis. World Neurosurg. 2019;128:e884-e894.
